Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Photogen Technologies,Inc (NasdaqSC:PHGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
140 Union Square Drive
New Hope, PA 18938
Phone: (215) 862-6860
Email: jonathan@troutgroup.com
Employees (last reported count): 12
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 69%
·Over the last 6 months:
 · 3 insider buys; 2.01M shares (7.7% of insider shares)
 · 4 insider sells; 2.00M shares
  (7.7% of insider shares)
·Institutional: 1% (5% of float)
(28 institutions)
·Net Inst. Buying: 107.0K shares (+16.11%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Photogen Technologies, Inc. is a development-stage biotechnology company focused on developing minimally invasive products for the treatment and diagnosis of cancer, pre-cancerous conditions and other diseases. The Company is developing compounds that react with energy for the purpose of destroying diseased cells, removing tissue or identifying and diagnosing disease. Compounds that react with light energy are called "photoactive agents," and those that react with ionizing radiation (which the Company generically refers to as X-rays) are called "radiosensitizers." The Company is also developing agents that are radiopaque and can be used to locate lymphnodes and diagnosis the presence or absence of cancer metastases. The Company has discovered and is conducting research on new methods and apparatus for using energy from lasers, X-rays or other sources to activate energy-sensitive compounds within tissue to produce a range of beneficial therapeutic and diagnostic outcomes.
More from Market Guide: Expanded Business Description

Financial Summary
Photogen Technologies, Inc. is an emerging development stage biotechnology company focused on developing minimally invasive products for the treatment and diagnosis of disease. For the three months ended 3/31/01, revenues remained flat at $0. Net loss applicable to Common increased 37% to $3.8 million. Results reflect the inclusion of a $696 thousand provision for future lease payments and decreased investment income.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, after tax earnings were -2,074. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Theodore Tannebaum, 67
Chairman
--  
Taffy Williams, Ph.D., 51
Pres, CEO, Director
$331K
Brooks Boveroux, 57
CFO, Sr. VP-Fin.
247K
Timothy Scott, Ph.D., 42
COO
117K
Reinhard Koenig, M.D., Ph.D., 40
Sr. VP, Medical and Regulatory Affairs
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:PHGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-June-2001
$0.93 
Recent Price$1.31 
52-Week High
on 5-Sep-2000
$8.188
Beta0.72 
Daily Volume (3-month avg)13.8K
Daily Volume (10-day avg)3,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-79.0%
52-Week Change
relative to S&P500
-71.8%
Share-Related Items
Market Capitalization$49.4M
Shares Outstanding37.7M
Float11.7M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.42 
Earnings (ttm)-$0.38 
Earnings (mrq)-$0.08 
SalesN/A 
Cash (mrq*)$0.11 
Valuation Ratios
Price/Book (mrq*)3.12 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDA (ttm*)-$11.4M
Income available to common (ttm)-$13.2M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-53.89%
Return on Equity (ttm)-68.66%
Financial Strength
Current Ratio (mrq*)4.70 
Debt/Equity (mrq*)0.04 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short97.0K
Percent of Float0.8%
Shares Short
(Prior Month)
100.0K
Short Ratio19.40 
Daily Volume5,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.